Niu M - Search Results

1

CRM1 is a direct cellular target of the natural anti-cancer agent plumbagin.

Liu X, Niu M, Xu X, Cai W, Zeng L, Zhou X, Yu R, Xu K. Liu X, et al. Among authors: niu m. J Pharmacol Sci. 2014;124(4):486-93. doi: 10.1254/jphs.13240fp. J Pharmacol Sci. 2014. PMID: 24739265 Free article.

2

Tautomycetin induces apoptosis by inactivating Akt through a PP1-independent signaling pathway in human breast cancer cells.

Niu M, Sun Y, Liu X, Tang L, Qiu R. Niu M, et al. J Pharmacol Sci. 2013;121(1):17-24. doi: 10.1254/jphs.12206fp. Epub 2012 Dec 26. J Pharmacol Sci. 2013. PMID: 23269238 Free article.

3

[Effect of AZD8330 on proliferation and apoptosis of multiple myeloma cells].

Yao Y, Bian YP, Xia DD, Pan B, Niu MS, Zhao K, Zeng LY, Xu KL. Yao Y, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014 Oct;22(5):1311-5. doi: 10.7534/j.issn.1009-2137.2014.05.024. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014. PMID: 25338579 Chinese.

4

Plumbagin induces growth inhibition of human glioma cells by downregulating the expression and activity of FOXM1.

Liu X, Cai W, Niu M, Chong Y, Liu H, Hu W, Wang D, Gao S, Shi Q, Hu J, Zhou X, Yu R. Liu X, et al. Among authors: niu m. J Neurooncol. 2015 Feb;121(3):469-77. doi: 10.1007/s11060-014-1664-2. Epub 2014 Dec 21. J Neurooncol. 2015. PMID: 25528634

5

Piperlongumine selectively suppresses ABC-DLBCL through inhibition of NF-κB p65 subunit nuclear import.

Niu M, Shen Y, Xu X, Yao Y, Fu C, Yan Z, Wu Q, Cao J, Sang W, Zeng L, Li Z, Liu X, Xu K. Niu M, et al. Biochem Biophys Res Commun. 2015 Jul 10;462(4):326-31. doi: 10.1016/j.bbrc.2015.04.136. Epub 2015 May 13. Biochem Biophys Res Commun. 2015. PMID: 25979358

6

Novel reversible selective inhibitor of nuclear export shows that CRM1 is a target in colorectal cancer cells.

Niu M, Chong Y, Han Y, Liu X. Niu M, et al. Cancer Biol Ther. 2015;16(7):1110-8. doi: 10.1080/15384047.2015.1047569. Epub 2015 May 21. Cancer Biol Ther. 2015. PMID: 25996664 Free PMC article.

7

Piperlongumine is a novel nuclear export inhibitor with potent anticancer activity.

Niu M, Xu X, Shen Y, Yao Y, Qiao J, Zhu F, Zeng L, Liu X, Xu K. Niu M, et al. Chem Biol Interact. 2015 Jul 25;237:66-72. doi: 10.1016/j.cbi.2015.05.016. Epub 2015 May 28. Chem Biol Interact. 2015. PMID: 26026911

8

Alantolactone induces G1 phase arrest and apoptosis of multiple myeloma cells and overcomes bortezomib resistance.

Yao Y, Xia D, Bian Y, Sun Y, Zhu F, Pan B, Niu M, Zhao K, Wu Q, Qiao J, Fu C, Li Z, Xu K. Yao Y, et al. Among authors: niu m. Apoptosis. 2015 Aug;20(8):1122-33. doi: 10.1007/s10495-015-1140-2. Apoptosis. 2015. PMID: 26033479

9

Antithymocyte globulin combined with cyclosporine A down-regulates T helper 1 cells by modulating T cell immune response cDNA 7 in aplastic anemia.

Zhu F, Qiao J, Zhong XM, Wu QY, Chen W, Yao Y, Niu MS, Fu CL, Zeng LY, Li ZY, Xu KL. Zhu F, et al. Med Oncol. 2015 Jul;32(7):197. doi: 10.1007/s12032-015-0647-2. Epub 2015 Jun 7. Med Oncol. 2015. PMID: 26049920

10

Novel reversible selective inhibitor of CRM1 for targeted therapy in ovarian cancer.

Liu X, Chong Y, Liu H, Han Y, Niu M. Liu X, et al. Among authors: niu m. J Ovarian Res. 2015 Jun 10;8:35. doi: 10.1186/s13048-015-0166-y. J Ovarian Res. 2015. PMID: 26055813 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,725 results

Search Page

Filters